MedTrace Logo

Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer

NCT04809025 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2025-09-29

No results posted yet for this study

Summary

This study aims to test the hypothesis that the diagnosis for histological type, histological grade, LAUREN type, HER-2 expression, MSI/dMMR status, and EBV status in gastric cancer is at least as reliable when performed on endoscopic biopsy specimens as on surgical resection specimens.

Conditions

  • Stomach Neoplasms
  • Endoscopy
  • Biopsy
  • Pathology

Interventions

DEVICE

endoscopy

gastroscope

PROCEDURE

Surgery

radical gastrectomy

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Dazhi Xu, PHD, MD · Fudan University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-24
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04809025 on ClinicalTrials.gov